In terms of angiogenesis, IGF2BP2 modulates the expression of ephrin type-A receptor 2 (EphA2) and vascular endothelial growth factor A (VEGFA) to facilitate vasculogenic mimicry in CRC [88]. Here, EPHA2 is linked to colorectal carcinoma.